Aggressive Infliximab Dosing Shows No Added Benefit in UC ...Middle East

Aggressive infliximab dosing did not provide additional clinical benefits for patients with steroid-refractory acute severe ulcerative colitis compared with standard dosing. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Aggressive Infliximab Dosing Shows No Added Benefit in UC )

Also on site :

• No Way: FBI Assesses That Venezuela Facilitating Migration of Gang Members to US
• Shannon Sharpe accused of choking female production assistant at Fox Sports prior to $50M rape lawsuit: report
• China fin min: Current world economic growth momentum is insufficient